Lipoprotein(a) and cardiovascular disease in individuals aged 70-100 years

31 August 2026 (10:53 - 11:01)

Organised by:

Abstract

Sign in to view the resources

About the speaker

Professor Borge Nordestgaard

Copenhagen University Hospital, Copenhagen (Denmark)

3 More presentations in this session

Presentation thumbnail

Comparative effectiveness of ticagrelor versus clopidogrel in older adults (≥75 years) with ST-segment elevation myocardial infarction: a target trial emulation study

Doctor R. Guo (Tianjin, CN)

Presentation thumbnail

Age-related amplification of inflammatory risk after percutaneous coronary Intervention: a 10-year large-sample prospective cohort study

Ms M. Liu (Beijing, CN)

Presentation thumbnail

CVMI-age quantifies multidimensional cardiovascular aging and predicts cardiovascular events: a Chinese community-based cohort study

Doctor H. Xie (Beijing, CN)

Access the full session

Session thumbnail

Cardiovascular disease in older adults: ageing, risk stratification, and outcomes

The Event

Event poster

ESC Congress 2026

31 August 2026 10:53 CET

You may be interested in

Congress Presentation

Low-density lipoprotein cholesterol, coronary plaque burden, and cardiovascular risk in individuals beyond 75 years of age

1 September 2025

Webinar

Lipoprotein(a): a modifiable risk factor of atherosclerotic cardiovascular disease

25 October 2024

Congress Presentation

The association between lipoprotein (a) levels and body composition

4 April 2025

Congress Presentation

The association of arterial biological age, genetic traits and cardiovascular risk factors

29 June 2021

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources